Defining and managing high-risk acute myeloid leukemia (AML) in 2026. Alibrahim MN, Elsayed MA, Alqahtani AN, Alshehri FS, et al. Ann Hematol 2026;105:416.

Read + Share

Amedeo Smart

Independent Medical Education

Alibrahim MN, Elsayed MA, Alqahtani AN, Alshehri FS, et al. Defining and managing high-risk acute myeloid leukemia (AML) in 2026. Ann Hematol 2026;105:416.
PMID: 42734831